Gout: Your Urate Tests and Flare History as Research Data

Every figure in this guide comes from a published source, linked where it appears and kept in CureCircle's evidence base with the source's own words. It is not medical advice. Read on 7 November 2026.

Gout is one of the few chronic conditions with a clear number to aim for: the urate level in the blood. Yet many people still have flares for years, stop their tablets, or never reach the target. What actually happened, the flares and what set them off, the doses and the blood tests, what made it easier or harder to keep going with treatment, is what research on gout needs, and the person with gout is the one who knows it.

How many people live with it

A Global Burden of Disease analysis found that in 2021, gout affected 57 million people globally, with 9.4 million new cases. An earlier GBD study counted 55.8 million people with gout in 2020, an increase of 22.5% since 1990.

The records worth keeping

NICE's 2022 guideline on gout describes the tests that leave records:

• A serum urate test to confirm the diagnosis: NICE says to measure the serum urate level in people with symptoms and signs of gout to confirm the clinical diagnosis.
• Monthly urate tests while treatment is adjusted: use monthly serum urate levels to guide dose increases until the target is reached. A run of these results shows exactly how treatment went.
• A yearly urate check once the target is reached, for people continuing urate-lowering therapy.
• Joint tests or imaging when the diagnosis is uncertain: joint aspiration and microscopy of synovial fluid, or X-ray, ultrasound or dual-energy CT.

Your own notes of flares, which joint, how long, and what you ate or drank before, fill in what the tests cannot. If you do not have your results, ask your practice for a copy.

What sharing it is worth

CureCircle values every contribution with a public benchmark built from what health data has sold for. A complete gout story with the records the guideline lists comes to about $64 per licence on the benchmark today. Every line and its source is on the gout page.

A licence is not a one-off sale: the same de-identified story can be licensed to several research teams, and you earn a share each time.

How to share it

You start by writing what you live with in your own words; a few quick questions follow, then an AI interviewer asks about the details only you know, and you rate every treatment you tried, from allopurinol to colchicine to changes in diet. You can add blood results and clinic letters as PDFs or photos, and the AI reads them into your own medical file. Before anything is shared, you read the de-identified summary and decide.

Start your story, or read what your health data is worth first.